CION Ameerpet
There is no single growth rate. Some brain tumours grow only a millimetre or two a year; a few high-grade ones change over weeks. This page explains slow versus fast growing tumours — and when to get checked.
If you have searched "how fast do brain tumours grow", you probably want a number. The honest answer is that there is no single growth rate — and that is reassuring more often than not. A brain tumour's speed is decided almost entirely by its type and its WHO grade, not by chance. Some tumours barely change for years; a few aggressive ones grow over weeks.
The vast majority of brain tumours — and almost all benign ones — grow slowly, over many months or years. A smaller number, the high-grade tumours, grow quickly and need prompt treatment. This page explains the difference between a slow growing and a fast growing brain tumour, how doctors measure real growth, and when a changing symptom is worth getting checked. It is written and reviewed by the neuro-oncology team at CION Cancer Clinics.
This page is general information, not a diagnosis. Only imaging and usually a biopsy can establish a tumour's type, grade, and growth rate. If a symptom worries you, see a doctor; if it is sudden and severe, treat it as an emergency.
Brain tumours are described by a WHO grade from 1 to 4, based on how the cells look under a microscope. The grade is the single best predictor of how quickly a tumour is likely to grow. These ranges are general and individual tumours vary.
| WHO grade | Typical growth speed | Common examples |
|---|---|---|
| Grade 1 (benign, slow) | Very slow — often millimetres a year; some never grow | Meningioma (most), pilocytic astrocytoma, many pituitary tumours |
| Grade 2 (low-grade) | Slow — gradual change over months to years | Diffuse astrocytoma, oligodendroglioma |
| Grade 3 (high-grade) | Moderately fast — change over months | Anaplastic astrocytoma, anaplastic oligodendroglioma |
| Grade 4 (malignant, fast) | Fast — can enlarge over weeks to a few months | Glioblastoma (GBM) |
Note: brain tumours are graded (how aggressive the cells are), not "staged" like most other cancers — because they rarely spread outside the brain. To understand grading further, see low-grade glioma and the fast-growing glioblastoma.
The 2021 European Association of Neuro-Oncology (EANO) guidance and the WHO classification, also reflected in NCCN protocols, now use molecular markers — not just appearance under the microscope — to predict how a glioma will behave. An IDH-mutated glioma typically grows more slowly and carries a better outlook than an IDH wild-type tumour of the same grade. This is why two tumours that look similar on a scan can have very different growth rates.
The clearest way to think about brain tumour growth rate is the difference between low-grade (slow) and high-grade (fast) tumours.
The cells look close to normal and divide slowly, so the tumour expands gradually over months to years. Symptoms tend to be subtle and slowly worsening — or absent altogether, which is why some are found by chance on a scan done for another reason. Many benign tumours like most meningiomas sit in this group. Treatment may be surgery, radiation, or simply watch-and-wait with repeat MRI when the tumour is small and causing no problems.
The cells look abnormal and divide rapidly, so the tumour can enlarge over weeks to a few months. Symptoms typically appear and worsen more quickly because the tumour raises pressure inside the skull and damages nearby tissue. Glioblastoma (Grade 4) is the best-known fast-growing type. These tumours usually need prompt combined treatment — surgery, radiation, and systemic therapy — coordinated by a neuro-oncology team.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centreTravelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationShare your name and number — we'll call you back within 30 minutes to schedule your consultation.
A short conversation with a CION oncologist — and, if needed, the right imaging — can tell you how a tumour is actually behaving. Free, confidential, and with no commitment to treatment.
Several factors together explain why one tumour grows quickly and another barely changes. These are the things a neuro-oncology team weighs up when judging likely growth.
The grade, set by a pathologist examining the tumour cells, is the strongest predictor of speed. Low-grade (Grade 1-2) tumours have cells that look near-normal and divide slowly, expanding over months to years. High-grade (Grade 3-4) tumours have abnormal, rapidly dividing cells and can enlarge over weeks to a few months. Grade — not how big the tumour looks on a single scan — is what tells doctors how urgently it needs treatment.
Different tumour types have characteristic behaviours. Most meningiomas are benign and grow very slowly; a fast-growing glioblastoma is a malignant glioma at the opposite end. A low-grade glioma sits in between — often slow for years but with potential to change over time. Knowing the exact type, confirmed by biopsy, is essential because it shapes both the expected growth rate and the treatment plan.
Modern classification uses molecular testing as well as appearance. The IDH mutation is the most important example: an IDH-mutated glioma typically grows more slowly and carries a better outlook than an IDH wild-type tumour of the same grade. Markers like these are tested on the biopsy sample and can change both the expected growth rate and the choice of treatment, which is why molecular testing is now standard for malignant gliomas.
A primary brain tumour starts in the brain and its growth follows its type and grade. A secondary tumour, or brain metastasis, is cancer that has spread to the brain from elsewhere — most often the lung, breast, kidney, or skin. The growth of a metastasis tends to mirror the behaviour of the original cancer, and these tumours are managed differently. If you have a known primary cancer, new brain lesions are usually secondary rather than a new primary tumour.
Where a tumour sits matters as much as how fast it grows. A small, slow-growing tumour in a critical area — near the pathways for speech, movement, or vision — can cause obvious symptoms early, while a larger, faster tumour in a "quiet" region may stay silent for longer. This is exactly why symptoms alone never reveal the growth rate, and why imaging is essential to see the size, position, and any change over time.
Age and individual tumour biology also play a part. Some tumour types are far more common at certain ages — glioblastoma usually after 60, and certain low-grade gliomas in younger adults. Two people with the same diagnosis can still see different growth rates because of differences in the tumour's genetics. This individual variation is one more reason doctors rely on measured evidence — grade, molecular tests, and serial scans — rather than a single predicted speed.
The takeaway: growth rate is read from grade, type, molecular markers, location, and serial imaging together — never from a single scan or symptom. Talk to a CION specialist if you would like your scans reviewed.
Rather than guessing, neuro-oncology teams measure growth using two complementary tools:
For some small, slow-growing, or incidentally found tumours, a deliberate watch-and-wait approach with repeat MRI is used — precisely to measure genuine growth before deciding whether treatment is needed. Acting too soon on a stable tumour can do more harm than good, so measured evidence guides the timing.
Both EANO and NCCN guidance support active monitoring with serial MRI for selected slow-growing or incidentally discovered brain tumours, rather than immediate intervention. The repeat scans give an objective growth rate over time — turning an unsettling "is it growing?" question into a measurable answer, and sparing many patients treatment they do not yet need.
You cannot feel a tumour's growth rate — but a rapidly changing symptom is a reason to get assessed promptly. The pattern that matters most is a symptom that is new, persistent, and progressive at the same time. Watch in particular for:
Emergency, not a scan booking: a sudden "worst headache of my life", sudden one-sided weakness or facial droop, sudden loss of vision, collapse, or a first seizure need emergency care now. Otherwise, a proper review can decide whether repeat imaging is needed to measure growth.
If you are anxious about how fast a tumour might be growing, the right step is a structured assessment rather than online guesswork. CION Cancer Clinics delivers imaging and diagnosis, molecular testing, medical and radiation oncology, and supportive care directly, and coordinates any neurosurgery with accredited neurosurgical partners. Every case is reviewed by our multidisciplinary tumour board before a plan is finalised.
At a free 45-minute consultation, a specialist reviews your history, examination, and any existing scans, explains what your tumour type and grade mean for growth, and arranges repeat MRI if it is needed to measure change over time. You deserve clear answers, and we walk this journey with you — with transparent costs and decisions made for healing, not billing.
Prefer to talk now? Call 18002028726 and speak to the CION team. Explore more in the brain cancer and tumour hub, see how common brain tumours are, or read about brain tumour treatment in Hyderabad.
Many people who come to CION worried about a brain tumour leave reassured after a single visit. If you'd value that clarity, book a free consultation or request a second opinion.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.It varies enormously — there is no single speed. Brain tumour growth depends almost entirely on the type and WHO grade of the tumour. A slow-growing Grade 1 tumour such as a meningioma or pilocytic astrocytoma may grow only a millimetre or two over a whole year, and some never grow at all. A fast-growing Grade 4 glioblastoma, by contrast, can roughly double in volume over weeks to a few months. Most brain tumours sit somewhere between these extremes. This is exactly why doctors do not give one "growth rate" — the type and grade, confirmed by imaging and usually a biopsy, determine how quickly a tumour behaves and how urgently it needs treatment.
A slow-growing (low-grade) brain tumour is graded WHO Grade 1 or 2 — the cells look close to normal under the microscope, the tumour expands gradually over months or years, and it often causes subtle, slowly worsening symptoms. Many can be watched or removed with surgery. A fast-growing (high-grade) brain tumour is Grade 3 or 4 — the cells look abnormal and divide rapidly, the tumour can enlarge over weeks, and symptoms tend to appear and worsen more quickly. High-grade tumours usually need prompt combined treatment. The grade is set by a pathologist looking at the tumour cells, supported by molecular testing such as IDH status, not by how big the tumour looks alone.
A high-grade tumour can change noticeably over a few weeks, which is why rapidly worsening symptoms are taken seriously. A fast-growing Grade 4 glioblastoma can enlarge measurably between scans only weeks apart. However, the great majority of brain tumours — and almost all benign ones — grow far more slowly, over many months or years. Rapid worsening of headaches, a first-ever seizure, new one-sided weakness, or sudden vision or speech change should prompt urgent medical review and a brain scan — not because every change means a fast tumour, but because the few situations that are urgent need to be ruled in or out quickly.
Often, but not always — and location matters as much as speed. A fast-growing tumour tends to produce symptoms that appear and worsen over a short period, because it raises pressure inside the skull and damages nearby tissue more quickly. But a tiny slow-growing tumour in a critical area — near the speech, movement, or vision pathways — can cause obvious symptoms while a larger, faster tumour in a "quiet" area stays silent for longer. This is why symptoms alone never tell you the growth rate. Only imaging, and usually a biopsy with molecular testing, can establish the tumour type, grade, and how it is likely to behave.
Doctors assess growth in two main ways. First, the WHO grade from a biopsy predicts likely behaviour: low-grade tumours grow slowly, high-grade ones quickly. Second, serial MRI scans taken weeks or months apart show whether a tumour has actually enlarged, stayed stable, or shrunk with treatment. For some slow-growing or benign tumours found by chance, an "watch-and-wait" approach with repeat MRI is used precisely to measure real growth before deciding on treatment. Molecular markers such as IDH mutation also refine the prediction, because IDH-mutated gliomas typically grow more slowly than IDH wild-type tumours of the same grade.
First, breathe — most brain tumours grow slowly, and worry is understandable but rarely matches the actual speed. The right step is a proper assessment rather than guessing from symptoms or online searches. CION Cancer Clinics provides imaging and diagnosis, molecular testing, medical and radiation oncology, and supportive care directly, and coordinates any neurosurgery with accredited neurosurgical partners. At your free 45-minute consultation a specialist reviews your history, examination, and any existing scans, and arranges repeat imaging if it is needed to measure growth. You can also request a free written second opinion. Explore the brain cancer and tumour hub or our brain tumour treatment page.
Disclaimer: This content is intended for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Brain tumour growth rates vary widely by type and grade, and the ranges described here are general. Always consult a qualified doctor for guidance specific to your situation, and treat sudden, severe symptoms as an emergency. The information on this page is periodically reviewed and updated by CION's medical team in line with current clinical guidelines.
Browse our complete guide to brain tumours and brain cancer — symptoms, scans, tumour types, treatment, prognosis and life after treatment. Tap any topic to read more.